Literature DB >> 25603830

When gout goes to the heart: does gout equal a cardiovascular disease risk factor?

Jasvinder A Singh1.   

Abstract

Entities:  

Keywords:  Cardiovascular Disease; Epidemiology; Gout; Outcomes research

Mesh：

Year:  2015        PMID： 25603830     DOI： 10.1136/annrheumdis-2014-206432

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN： 0003-4967            Impact factor:   19.103


× No keyword cloud information.
  10 in total

1.  Association between arthritis and cardiovascular risk factors in community-based adults: an opportunity to target cardiovascular risk.

Authors:  Julia Sewell; Sultana Monira Hussain; Yuanyuan Wang; Anita E Wluka; Yuan Z Lim; Melinda J Carrington; Katherine Samaras; Flavia M Cicuttini
Journal:  BMC Cardiovasc Disord       Date:  2022-05-19       Impact factor: 2.174

Review 2.  Hyperuricemia and Cardiovascular Risk.

Authors:  Lauren Shahin; Komal M Patel; Milad K Heydari; Marc M Kesselman
Journal:  Cureus       Date:  2021-05-05

3.  The risk of atrial fibrillation in patients with gout: a nationwide population-based study.

Authors:  Yu-Jui Kuo; Tzu-Hsien Tsai; Hui-Ping Chang; Sarah Chua; Sheng-Ying Chung; Cheng-Hsu Yang; Cheng-Jei Lin; Chiung-Jen Wu; Chi-Ling Hang
Journal:  Sci Rep       Date:  2016-09-07       Impact factor: 4.379

4.  Is gout a risk equivalent to diabetes for stroke and myocardial infarction? A retrospective claims database study.

Authors:  Jasvinder A Singh; Rekha Ramachandaran; Shaohua Yu; Shuo Yang; Fenglong Xie; Huifeng Yun; Jie Zhang; Jeffrey R Curtis
Journal:  Arthritis Res Ther       Date:  2017-10-17       Impact factor: 5.156

5.  Do etoricoxib and indometacin have similar effects and safety for gouty arthritis? A meta-analysis of randomized controlled trials.

Authors:  Tzu-Min Lin; Jia-En Chi; Chi-Ching Chang; Yi-No Kang
Journal:  J Pain Res       Date:  2018-12-19       Impact factor: 3.133

Review 6.  A glance into the future of gout.

Authors:  Francisca Sivera; Mariano Andres; Nicola Dalbeth
Journal:  Ther Adv Musculoskelet Dis       Date:  2022-07-28       Impact factor: 3.625

7.  Cardiovascular risk associated with allopurinol or benzbromarone treatment in patients with gout.

Authors:  Yeonghee Eun; Heewon Han; Kyunga Kim; Seonyoung Kang; Seulkee Lee; Hyungjin Kim; Jaejoon Lee; Eun-Mi Koh; Hoon-Suk Cha
Journal:  Ther Adv Musculoskelet Dis       Date:  2022-08-10       Impact factor: 3.625

8.  Allopurinol reduces the risk of myocardial infarction (MI) in the elderly: a study of Medicare claims.

Authors:  Jasvinder A Singh; Shaohua Yu
Journal:  Arthritis Res Ther       Date:  2016-09-22       Impact factor: 5.156

9.  An evaluation of longitudinal changes in serum uric acid levels and associated risk of cardio-metabolic events and renal function decline in gout.

Authors:  Rishi J Desai; Jessica M Franklin; Julia Spoendlin-Allen; Daniel H Solomon; Goodarz Danaei; Seoyoung C Kim
Journal:  PLoS One       Date:  2018-02-28       Impact factor: 3.240

10.  Repositioning of the β-Blocker Carvedilol as a Novel Autophagy Inducer That Inhibits the NLRP3 Inflammasome.

Authors:  Wei-Ting Wong; Lan-Hui Li; Yerra Koteswara Rao; Shih-Ping Yang; Shu-Meng Cheng; Wen-Yu Lin; Cheng-Chung Cheng; Ann Chen; Kuo-Feng Hua
Journal:  Front Immunol       Date:  2018-08-22       Impact factor: 7.561
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.